• SENSEX 81,592.45
    -318.56 (--0.39%)
  • BANKNIFTY 61,034.10
    -484.40 (--0.79%)
  • NSE
    2,007.60 2,007.60(%)
  • Hitachi Energy
    32,245.70 38,800.00(%)
  • SBI
    1,074.60 933.85(%)
  • TD Power Systems
    685.00 856.00(%)
  • Reliance Industries
    1,351.00 1,611.20(%)
  • Amber Enterp.
    6,909.00 8,970.00(%)
  • Bharti Airtel
    2,123.80 2,174.70(%)
  • Larsen & Toubro
    4,128.70 3,288.65(%)
  • Kalyan Jewellers
    684.95 327.15(%)
  • SBI Funds Mgt.
    512.45 433.55(%)
  • Cupid
    363.25 53.66(%)
  • Apollo Micro Sys
    477.55 477.55(%)
  • M & M
    3,330.00 2,743.15(%)
  • 3M India
    28,259.25 26,400.05(%)
  • Kotak Mah. Bank
    484.00 345.40(%)
  • Bajaj Finance
    1,118.60 1,177.60(%)
  • Cholaman.Inv.&Fn
    1,810.15 1,299.80(%)
  • Netweb Technol.
    4,272.00 5,810.00(%)
  • BLS Polymers
    279.80 288.00(%)
  • Maruti Suzuki
    12,800.00 10,984.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5905.0
  • ISIN : INE646B01010
281.65 10 (3.62%)
  • As on 13 Nov 2026 (EOD)

  • Today’s Low

    273.95

  • Today’s High

    284.00

  • Open

    275.00

  • Perv Close

    271.80

  • 52W Low

    212.40

  • 52W High

    447.65

Key Indicators

  • P/E(TTM)

    38.62

  • Mar.Cap (₹Cr.)

    396.08

  • Div & Yield %

    0.34

  • Book Value(₹)

    211.63

  • Debt-Equity Ratio

    3.62

  • AGM Date

    13-Nov-2026

  • EPS

    7.32

  • P/E Ratio

    38.62

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    396.08

  • RONW (%)

    4.74

  • ROCE (%)

    8.14

Score Board

  • Equity (₹ in Cr.)

    14.06

  • BV (₹)

    211.60

  • Sales( ₹ in Cr.)

    178.85

  • NP (in Cr.)

    9.41

  • NP Var(%)

    0.0

  • Div%

    10.0

  • CPS (₹)

    11.70

  • EPS (₹)

    6.70

  • Traded Value (₹ in Lakhs)

    397.56

  • 52 Week High

    447.65

  • 52 Week Low

    212.40

  • Price BSE

    283.0

  • Price NSE

    282.00

  • Market Capital( in Cr.)

    397.56

  • P/C Ratio

    24.20

  • P/E Ratio

    42.30

  • Price Vs.BV

    6.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 178.85 151.46 172.39 137.88 115.45 110.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 178.85 151.46 172.39 137.88 115.45 110.15
Other Income 3.10 6.23 2.30 2.46 1.72 0.75
Stock Adjustments -7.42 6.08 13.32 10.30 3.34 -1.04
Total Income 174.53 163.77 188.01 150.64 120.51 109.86
EXPENDITURE :            
Raw Materials 91.81 88.83 104.70 81.80 55.69 65.84
Power and Fuel Cost 8.05 6.94 7.12 5.67 5.86 2.68
Employee Cost 22.79 21.57 22.12 18.57 14.50 8.79
Other Manufacturing Expenses 14.23 10.87 10.24 8.70 9.60 7.37
Selling and Administration Expenses 13.91 11.01 12.42 6.65 7.50 3.94
Miscellaneous Expenses 1.20 1.21 1.87 2.18 1.52 0.46
Employee Benefit Expenses 22.79 21.57 22.12 18.57 14.50 8.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 151.98 140.43 158.47 123.56 94.69 89.08
Operating Profit 22.54 23.34 29.55 27.08 25.82 20.78
Interest 3.93 3.60 5.65 3.39 1.94 1.51
Gross Profit 18.61 19.74 23.90 23.69 23.88 19.27
Depreciation 7.06 6.96 7.01 6.35 5.77 2.52
Profit Before Tax 11.55 12.78 16.89 17.34 18.11 16.75
Current Tax 2.55 3.64 4.22 3.70 3.98 4.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.41 -0.31 -0.63 -1.37 -0.78 0.12
Reported Net Profit 9.41 9.45 13.30 15.00 14.91 12.49
Extraordinary Items 0.00 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 9.41 9.45 13.30 15.01 14.91 12.49
Adjustment below Net Profit 0.47 0.26 0.00 0.09 0.00 0.00
P & L Balance brought forward 102.61 94.18 82.15 68.32 54.43 42.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.36 1.27 1.27 1.27 1.22 0.61
P & L Balance carried down 111.13 102.61 94.18 82.15 68.12 54.43
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 1.00 1.00
Earnings Per Share-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Earnings Per Share(Adj)-Unit Curr 6.94 7.43 10.46 11.86 12.20 10.22
Book Value 199.90 171.17 164.54 152.30 121.18 109.98
Book Value(Adj)-Unit Curr 199.90 171.17 164.54 152.30 121.18 109.98

Shareholding Pattern

  • Promoter Group

    42.57%

  • Public Share Holding

    57.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,987,095 42.57 5,987,095 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,987,095 42.57 5,987,095 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.05 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 608,892 4.33 608,892 2
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,491 0.02 2,491 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 316 0.00 316 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 618,699 4.40 618,699 6
2] Non Institution
Bodies Corporate 281,701 2.00 280,201 98
Clearing Members 10,403 0.07 10,403 3
Directors of their Relatives 70,194 0.50 70,194 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 140,854 1.00 140,654 183
Foreign Non Institution Other 1,694,820 12.05 1,694,820 2
Hindu Undivided Families 385,973 2.74 385,973 380
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 847,105 6.02 847,105 20
Individuals holding nominal share capital up to Rs. 1 lakh 3,656,387 26.00 3,616,767 10,957
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 326,861 2.32 326,861 3
Sub Total 7,457,021 53.03 7,415,701 11,655
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 14,062,815 100.00 14,021,495 11,662

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

  • Medicamen Biotech Ltd
  • BSE Code : 5905.0
  • ISIN : INE646B01010

  • Incorporation Year

    1993

  • Registered Office

    1506 Chiranjiv Tower 43
    Nehru Place, New Delhi,
    New Delhi-110019

  • Telephone

    91-11-47589500

  • FAX

    91-11-26213081

  • Chairman

    Rahul Bishnoi

  • Managing Director

  • Company Secretary

    Parul Choudhary

  • Auditor

    Rai Qimat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Medicamen Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Biotec 282.70 181.95 178.85 38.62 5.46
Abbott India 26,413.45 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,039.00 2,304.07 2,275.58 84.95 27.86
Glaxosmi. Pharma 2,669.55 3,932.76 3,790.20 39.67 58.17
Evonile Pharma 1,520.30 393.10 354.33 -1,333.60 15.94
Cipla 1,393.00 20,102.60 18,979.95 42.46 13.88
Bliss GVS Pharma 673.00 773.53 729.81 43.87 12.51
Amrutanjan Healt 509.00 520.13 502.55 25.68 24.16
Fermenta Biotec. 473.80 474.15 450.25 22.39 18.77
Guj. Themis Bio. 389.25 168.25 165.82 104.08 18.05
Ambalal Sarabhai 38.59 19.52 3.94 65.41 6.77